Stem-cell therapies in critical limb ischemia
Background: Due to stimulation of muscular regeneration in ischemic extremities and increasing blood flow, stem cells are considered a promising new strategy for patients with critical limb ischemia (CLI). So, it is demonstrated that mesenchymal stem cells (MSCs), mononuclear cells derived from bo...
Main Authors: | Sergiu Visnevschi, Tatiana Malcova, Anatol Calistru, Viorel Nacu |
---|---|
Format: | Article |
Language: | English |
Published: |
Scientific Medical Association of Moldova
2021-03-01
|
Series: | The Moldovan Medical Journal |
Subjects: | |
Online Access: | http://moldmedjournal.md/wp-content/uploads/2021/03/moldovan-med-j-2021-64-1-visnevschi-et-al-full-text.pdf |
Similar Items
-
What Ails Diagnosis of Peripheral Arterial Disease/Critical Limb Ischemia/Critical Limb-threatening Ischemia in India?
by: Kalkunte R Suresh
Published: (2017-01-01) -
Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia
by: Tianyue Pan, et al.
Published: (2019-01-01) -
Critical Limb Ischemia: Current Trends and Future Directions
by: Martin Teraa, et al.
Published: (2016-02-01) -
Combination of cilostazol and clopidogrel attenuates Rat critical limb ischemia
by: Sheu Jiunn-Jye, et al.
Published: (2012-08-01) -
Current review with evolving management strategies in critical limb ischemia
by: Arun Sharma
Published: (2019-07-01)